Sysmex : and JCR Pharmaceuticals Establish a Joint Venture in the Field of Regenerative Medicine and Cell Therapy- Aiming for the Research & Development and Early Commercialization of Regenerative Medicine Products Using Stem Cells, etc. -

(marketscreener.com) In recent years, the significant potential of regenerative medicine and cell therapy have been established in particular in areas that have traditionally been difficult to address with conventional chemically synthesized low molecular weight drugs1 or biopharmaceuticals,2 such as the restoration of tissues and functions lost as a...https://www.marketscreener.com/quote/stock/SYSMEX-CORPORATION-6492200/news/Sysmex-and-JCR-Pharmaceuticals-Establish-a-Joint-Venture-in-the-Field-of-Regenerative-Medicine-and-41911205/?utm_medium=RSS&utm_content=20221003